Gilotrif savings card: as little as $0 a month with commercial insurance

How to pay the least

Ask for the cash price

Gilotrif

We didn’t find one.

Ask your pharmacy for Gilotrif’s cash price, and one or two other pharmacies too.
Gilotrif’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Boehringer Ingelheim Cares Foundation Patient Assistance Program. Or call 1-800-556-8317.

See if you qualify

Compare every option

Brand nameGilotrif

Authorized genericafatinib

Regular genericafatinib

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Gilotrif?

The original

–

Brand nameThe maker’s card

Copay Program for GILOTRIF (CareConnect4Me)

Savings card from Boehringer Ingelheim

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a month

Or call 1-877-546-5349.

In the maker’s words

“You may receive GILOTRIF for as little as $0 per month.”

From the maker’s offer on patient.boehringer-ingelheim.com, checked October 27, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Gilotrif itself, from the same company, sold without the brand name, and usually for less. For now Gilotrif is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

GILOTRIF is a kinase inhibitor indicated for:

First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test Limitations of Use: Safety and efficacy of GILOTRIF were not established in patients whose tumors have resistant EGFR mutations
Treatment of patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy

Source: the FDA label for Gilotrif (Boehringer Ingelheim Pharmaceuticals, Inc.), November 13, 2025. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked October 27, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/gilotrif/